# Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2

> **NCT07495865** · — · RECRUITING · sponsor: **Glyance** · enrollment: 87 (estimated)

## Conditions studied

- Wrinkles

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07495865
- **Lead sponsor:** Glyance
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-08
- **Primary completion:** 2027-03-12
- **Final completion:** 2027-03-12
- **Target enrollment:** 87 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07495865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07495865, "Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07495865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*